Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Responsible innovation in human germline gene editing: Background document to the recommendations of ESHG and ESHRE

De Wert, Guido, Heindryckx, Björn, Pennings, Guido, Clarke, Angus ORCID: https://orcid.org/0000-0002-1200-9286, Eichenlaub-Ritter, Ursula, van El, Carla G., Forzano, Francesca, Goddijn, Mariëtte, Howard, Heidi C., Radojkovic, Dragica, Rial-Sebbag, Emmanuelle, Dondorp, Wybo, Tarlatzis, Basil C. and Cornel, Martina C. 2018. Responsible innovation in human germline gene editing: Background document to the recommendations of ESHG and ESHRE. European Journal of Human Genetics 26 , pp. 450-470. 10.1038/s41431-017-0077-z

[thumbnail of Responsible innovation in human germline gene editing Background document to the recommendations of ESHG and ESHRE.pdf]
Preview
PDF - Accepted Post-Print Version
Download (1MB) | Preview

Abstract

Technological developments in gene editing raise high expectations for clinical applications, including editing of the germline. The European Society of Human Reproduction and Embryology (ESHRE) and the European Society of Human Genetics (ESHG) together developed a Background document and Recommendations to inform and stimulate ongoing societal debates. This document provides the background to the Recommendations. Germline gene editing is currently not allowed in many countries. This makes clinical applications in these countries impossible now, even if germline gene editing would become safe and effective. What were the arguments behind this legislation, and are they still convincing? If a technique could help to avoid serious genetic disorders, in a safe and effective way, would this be a reason to reconsider earlier standpoints? This Background document summarizes the scientific developments and expectations regarding germline gene editing, legal regulations at the European level, and ethics for three different settings (basic research, preclinical research and clinical applications). In ethical terms, we argue that the deontological objections (e.g., gene editing goes against nature) do not seem convincing while consequentialist objections (e.g., safety for the children thus conceived and following generations) require research, not all of which is allowed in the current legal situation in European countries. Development of this Background document and Recommendations reflects the responsibility to help society understand and debate the full range of possible implications of the new technologies, and to contribute to regulations that are adapted to the dynamics of the field while taking account of ethical considerations and societal concerns.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Publisher: Nature Publishing Group: Open Access Hybrid Model Option B
ISSN: 1018-4813
Date of First Compliant Deposit: 5 February 2018
Date of Acceptance: 18 November 2017
Last Modified: 19 Nov 2023 02:58
URI: https://orca.cardiff.ac.uk/id/eprint/108763

Citation Data

Cited 22 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics